Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01929460 · ClinicalTrials.gov registry record · NA
A Pilot Study on the Use of Prophylactic Antibiotics for EUS-guided Pancreatic Cyst Aspiration
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT01929460 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 26 participants.
The verdict
NCT01929460, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
Our hypothesis is that a single dose of antibiotics at time of EUS-guided pancreatic cyst aspiration is equally effective to the usual regimen of 3 days of post-procedural antibiotics.
Interventions
- DRUG Ciprofloxacin
- OTHER Placebo (for ciprofloxacin)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2014-01 |
| Est. Completion | 2014-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01929460
The ClinicalTrials.gov registry entry for NCT01929460 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ciprofloxacin is the first listed.
NCT01929460 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01929460 about?
NCT01929460 is a clinical study titled "A Pilot Study on the Use of Prophylactic Antibiotics for EUS-guided Pancreatic Cyst Aspiration". Our hypothesis is that a single dose of antibiotics at time of EUS-guided pancreatic cyst aspiration is equally effective to the usual regimen of 3 days of post-procedural antibiotics.
What is the current status of trial NCT01929460?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2014-01. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01929460?
The interventions under investigation include: Ciprofloxacin (DRUG), Placebo (for ciprofloxacin) (OTHER).
Who is sponsoring clinical trial NCT01929460?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.